CuraSen Therapeutics Presents Positive Phase 1 Safety, Pharmacokinetics and Pharmacodynamics Data with CuraAX (CST-3056) at the 2025 American Autonomic Society (AAS) International Symposium Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback